Table 3 Clinical and demographic characteristics stratified according awareness of hypoglycemia evaluated by the Clarke and Gold questionnaires
Clarke | Gold | |||||
|---|---|---|---|---|---|---|
Aware (n = 76) | IAH (n = 47) | p | Aware (n = 92) | IAH (n = 31) | p | |
IAH (%) | 61.7 | 38.3 | 74.8 | 25.2 | ||
Sex (% male) | 33.1 | 17.9 | 42.3 | 8.9 | ||
Age | 38.01 (11.16) | 42.09 (11.73) | 0.060 | 39.2 (11.25) | 40.68 (12.36) | 0.558 |
BMI | 24.19 (3.42) | 24.56 (3.59) | 0.568 | 24.17 (3.42) | 24.81 (3,60) | 0.390 |
Diabetes duration | 20.17 (10.21) | 25.91 (9.29) | 0.002 | 21.53 (10.32) | 24.84 (9.64) | 0.110 |
Insulin dose | 0.72 (0.23) | 0.69 (0.20) | 0.467 | 0.71 (0.22) | 0.69 (0.20) | 0.640 |
Glycaemia | 191.79 (106.53) | 166.43 (102.62) | 0.196 | 192.61 (110.8) | 150.9 (80.9) | 0.028 |
HbA1C (%) | 8.62 (1.52) | 8.09 (1.36) | 0.047 | 8.52 (1.49) | 8.13 (1.41) | 0.199 |
GFRe (mL/min/1,73 m2) | 84.05 (36,4) | 59.96 (40,68) | 0.001 | 75.82 (39.55) | 71.97 (40.65) | 0.648 |
No of hypoglycemia/week | 2.2 (1.53) | 3.43 (1.97) | 0.000 | 2.38 (1.64) | 3.52 (2.03) | 0.007 |
No severe hypoglycemia in 6 m | 0.93 (1.82) | 3.74 (3.27) | 0.000 | 1.43 (2.13) | 3.71 (3.81) | 0.003 |
No severe hypoglycemia in 12 m | 2.05 (3.97) | 7.28 (6.10) | 0.000 | 3.12 (4.71) | 6.81 (6.70) | 0.001 |
Intravenous glucose need | 0.11 (0.32) | 0.63 (0.48) | 0.000 | 0.25 (0.43) | 0.5161 (0.50) | 0.006 |